CFG
RMD icon

Clayton Financial Group’s ResMed RMD Stock Holding History

Clayton Financial Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10
Closed -$2.25K – 462
2026
Q1 		$2.25K Hold
10
– – ﹤0.01% 446
2025
Q4 		$2.41K Buy
+10
New +$2.56K ﹤0.01% 424

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Clayton Financial Group's RMD Position: Q2 2026 in Review

Clayton Financial Group sold out of ResMed (RMD) in Q2 2026, closing a stake of 10 shares — an estimated $2.25K sold.

Clayton Financial Group first reported a position in RMD in Q4 2025 and held it in 2 quarters. The position peaked at $2.41K in Q4 2025. 139 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Clayton Financial Group reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Clayton Financial Group sold 10 ResMed shares in Q2 2026, an estimated $2.25K.
  • Clayton Financial Group first reported a position in ResMed in Q4 2025 and held it in 2 quarters.
  • Clayton Financial Group's ResMed position peaked at $2.41K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Clayton Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.